Recombinant interferon-alpha-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study.
Imai Y, Kawata S, Tamura S, Ito N, Seki K, Nishiuchi M, Shinji Y, Kiriyama K, Himeno S, Minami Y, Kashihara T, Kawakami F, Maeda H, Yabuuchi I, Nishioka M, Shirai Y, Fukuda K, Kiso S, Ito T, Igura T, Doi Y, Matsuzawa Y.
Imai Y, et al. Among authors: yabuuchi i.
Liver. 1997 Apr;17(2):88-92. doi: 10.1111/j.1600-0676.1997.tb00786.x.
Liver. 1997.
PMID: 9138278
Clinical Trial.